Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Recurrent Breast Cancer|Stage IV Breast Cancer
Interventions: BIOLOGICAL: bevacizumab|DRUG: docetaxel|OTHER: laboratory biomarker analysis
Sponsor: National Cancer Institute (NCI)